Pseudogene KRT17P3 Promotes NSCLC Progression Through Mir-338-3p/USP7/C-Myc
KRT17P3 plays a pivotal role in NSCLC progression by regulating the USP7/c-Myc axis via miR-338-3p, suggesting its potential as both a prognostic biomarker and a therapeutic target for NSCLC treatment.
Authors
- Liping Wei (ORCID: https://orcid.org/0000-0002-4296-9851)
- Zhaoyan Jiang (ORCID: https://orcid.org/0000-0002-8210-342X)
- S L Chen
- Ning Xia (ORCID: https://orcid.org/0000-0002-3618-6383)
- Yan Chang
- Jun Kong (ORCID: https://orcid.org/0000-0002-9398-8526)
- Zhibo Hou
Institutions
- Nanjing Brain Hospital (CN)
- Nanjing Chest Hospital (CN)
- Shanghai Institute of Pharmaceutical Industry (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Anticancer Research
- Published
- 2024-12-01
- DOI
- https://doi.org/10.21873/anticanres.17367
- Primary Topic
- Cancer-related gene regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00